Chemomab Therapeutics (CMMB) Institutional Ownership $1.58 -0.01 (-0.63%) (As of 12:44 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Chemomab Therapeutics (NASDAQ:CMMB)CurrentInstitutional OwnershipPercentage46.05%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.91MNumber ofInstitutional Sellers(last 12 months)0 Get CMMB Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CMMB Institutional Buying and Selling by Quarter Ad Diversified Trading InstituteCombine the QQQ, IWM and SPY in one tradeIf you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. Chemomab Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Sphera Funds Management LTD.1,214,575$1.91M0.3%N/A8.458% 2/1/2023 Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271% 2/14/2022 GSA Capital Partners LLP11,277$78K0.0%N/A0.099% 1/28/2022 ARK Investment Management LLC267,292$1.84M0.0%+48.1%2.344% 11/17/2021 Yahav Achim Ve Achayot Provident Funds Management Co Ltd.3,097$34K0.0%N/A0.027% 11/5/2021 Advisor Group Holdings Inc.54,821$608K0.0%N/A0.481% 11/3/2021 Meitav Dash Investments Ltd.37,567$416K0.0%-7.6%0.330% 9/17/2021 Virtu Financial LLC13,180$251K0.0%N/A0.116% 8/25/2021 Marshall Wace LLP63,554$1.21M0.0%N/A0.558% 8/25/2021Marshall Wace North America L.P.44,035$837K0.0%N/A0.386% 8/18/2021 Ikarian Capital LLC290,534$5.53M0.4%N/A2.640% 8/18/2021 Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.370% 8/17/2021 Boothbay Fund Management LLC54,729$1.04M0.0%-11.4%0.512% 8/16/2021 Marshall Wace LLP63,554$1.21M0.0%N/A0.594% 8/5/2021 Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.380% 5/18/2021 Orbimed Advisors LLC2,578,174$74.02M0.7%N/A110.320% 5/13/2021 Renaissance Technologies LLC7,023$202K0.0%N/A0.301% 5/6/2021 Meitav Dash Investments Ltd.8,311$239K0.0%N/A0.356% (Data available from 1/1/2016 forward) CMMB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CMMB shares? During the previous two years, the following institutional investors and hedge funds held shares of Chemomab Therapeutics shares: Sphera Funds Management LTD. ($1.91M), Kestra Private Wealth Services LLC ($100K).Learn more on CMMB's institutional investors. What percentage of Chemomab Therapeutics stock is owned by institutional investors? 46.05% of Chemomab Therapeutics stock is owned by institutional investors. Learn more on CMMB's institutional investor holdings. Which institutional investors have been buying Chemomab Therapeutics stock? The following institutional investors have purchased Chemomab Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($1.21M), and Kestra Private Wealth Services LLC ($31.24K). How much institutional buying is happening at Chemomab Therapeutics? Institutional investors have bought a total of 1,245,816 shares in the last 24 months. This purchase volume represents approximately $2.01M in transactions. Related Companies NVCT Institutional Ownership EPRX Institutional Ownership RANI Institutional Ownership ANIX Institutional Ownership ASRT Institutional Ownership ADAG Institutional Ownership PWUP Institutional Ownership CTMX Institutional Ownership ME Institutional Ownership ANL Institutional Ownership This page (NASDAQ:CMMB) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
